Conclusions In this real-world, retrospective, observational study, adults with sub-optimally controlled T2D on GLP-1 RA therapy, initiating use of FSL, resulted in a significant improvement in A1c levels after 6 months of CGM use
doi: 10.1016/0891-5849(94)90030-2
The drug may no longer be FDA-approved
In the recommended dosages, the blue shade of the finished product is very diluted and does not produce residual coloring on the hair strands or scalp
According to official guidelines, maintaining these temperature limits is essential to preserve the medications effectiveness
It contrasts that with peptide medications like semaglutide and tirzepatide, which bind those receptors and produce sustained systemic effects on appetite, gastric motility, and insulin secretion